Dgcef T 250mg/31.25mg Injection
Marketer
Kenrox Healthcare Pvt. Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Dgcef T 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth, thus limiting infection spread. Administration must be strictly under medical guidance; adherence to the prescribed dosage schedule is crucial. Complete the entire course of treatment, regardless of symptom improvement, as premature cessation can reduce its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Report any worsening side effects to your physician immediately. Seek urgent medical attention for allergic reactions such as rash, itching, swelling, or breathing difficulties. Inform your doctor about all current medications before starting this treatment, including those for pre-existing conditions. Pregnant or nursing individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Rest, a balanced diet, and ample hydration are vital for optimal recovery. Your physician may order blood tests and other diagnostics to monitor the treatment's effectiveness.
Primary Ingredients of Dgcef T 250mg/31.25mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Dgcef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Dgcef T 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Dgcef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Dgcef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Dgcef T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum injection (250mg/31.25mg) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Dgcef T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administering Dgcef T 250mg/31.25mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Dgcef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Dgcef T (250mg/31.25mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data on the administration of Dgcef T 250mg/31.25mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 250mg/31.25mg Dgcef T Injection requires careful administration in individuals with advanced liver impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for this injection are not advised for patients exhibiting mild or moderate hepatic dysfunction.
What if you forget to take Dgcef T 250mg/31.25mg Injection :
Omitting a scheduled dose of Dgcef T 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Dgcef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently